Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10550118 JAK inhibitors containing a 4-membered heterocyclic amide

Patent 10550118 was granted and assigned to Theravance on February, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Steven D. E. Sullivan0

Cameron Smith0

Lori Jean Van Orden0

Melanie A. Kleinschek0

Paul R. Fatheree0

Gary E. L. Brandt0

Glenn D. Crater0

Date of Patent

February 4, 2020

Patent Application Number

16511410

Date Filed

July 15, 2019

Patent Citations

US Patent 10196393 JAK inhibitors containing a 4-membered heterocyclic amide

0

Patent Citations Received

US Patent 12122773 Crystalline hydrate of a JAK inhibitor compound

0

US Patent 10836763 5 to 7 membered heterocyclic amides as JAK inhibitors

US Patent 10844057 Process for preparing JAK inhibitors and intermediates thereof

0

US Patent 10947229 Dimethyl amino azetidine amides as JAK inhibitors

0

US Patent 11634419 Dimethyl amino azetidine amides as JAK inhibitors

0

US Patent 11702415 Crystalline hydrate of a JAK inhibitor compound

0

US Patent 11713315 5 to 7 membered heterocyclic amides as JAK inhibitors

0

US Patent 11299492 JAK kinase inhibitor compounds for treatment of respiratory disease

0

...

Patent Primary Examiner

Joseph R Kosack

Patent abstract

The invention provides compounds of formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10550118 JAK inhibitors containing a 4-membered heterocyclic amide

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool